Implant Delivery

Clinuvel has developed a novel, controlled-release, subcutaneous implant formulation for the delivery of afamelanotide. Roughly the size of a grain of rice, the implant releases the drug over approximately 2 weeks. After 2 days, skin pigment (melanin) is increased, with the effect lasting up to two months.